Loading
No insider purchase over the last 90 days. The latest, by Gawlick Rainer, was filed 07 Aug 2025.
Insider Decl.
364
Thresholds
n/a
Buy Volume
€1M
7 ops. · all time
Sell Volume
€25M
76 ops. · all time
Who traded when
BuySaleDaniel Schumacher3 sales
Michael R. Kenison3 sales
Rainer Gawlick1 buy
Suresh Krishna1 buy
Since the insiders bought
- +92.3%Entry US$46.62 · Close at T+365 US$89.66
- +92.1%Entry US$46.29 · Close at T+365 US$88.91
- +66.8%Entry US$29.36 · Close at T+365 US$48.96
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 14,828 of 26,248 companies
47.7
score / 100
Value33
Quality62
FCF yld2.8%
Earn yld1.0%
EV/EBITDA35.8x
ROE4.5%
Gross mgn44%
Net mgn4.0%
Debt/EBITDA0.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
US$89.69
Analyst consensus
4 analysts1.60/5
US$87.00Target US$95.50(+6%)US$110.00
Income statement
RevenueUS$533.1M
Gross profitUS$237.1M44% margin
EBITDAUS$60M11% margin
Net incomeUS$21.2M5.4% margin
Valuation
PER (trailing)71.2x
PER (forward)37.6x
P/Book3.1x
Beta1.38
Balance sheet & cash
Market capUS$2.1B
Total debtUS$3M
Free Cash FlowUS$59.7M
Debt / Equity0%
Profitability & ownership
ROE4.5%
ROA3.3%
% insiders1.3%
% institutions95.9%
Last declaration on 25 September 2026
Declarations364 total
1,143 shares@ US$95.7950.0053% mcap9.0% of flowCommonSEC144:0001950047-26-009826
5,000 shares@ US$95.32090.023% mcap32.5% of flowCommon StockSEC:0001628280-26-063573:0
1,800 shares@ US$95.85250.0083% mcap14.2% of flowCommonSEC144:0001950047-26-009788
5,000 shares@ US$89.130.021% mcap51.9% of flowCommonSEC144:0001950047-26-009804
100 shares@ US$85.000.0004% mcap0.6% of flowCommon StockSEC:0001628280-26-062704:0
4,900 shares@ US$85.21130.020% mcap28.3% of flowCommon StockSEC:0001628280-26-062704:1
4,900 shares@ US$83.240.019% mcap47.2% of flowCommonSEC144:0001950047-26-009618
100 shares@ US$79.090.0004% mcap0.9% of flowCommonSEC144:0001950047-26-009570
10,753 shares@ US$88.14160.058% mcap76.9% of flowCommonSEC144:0001950047-26-007656
2,210 shares0Common StockSEC:0001628280-26-037251:0
2,210 shares0Common StockSEC:0001628280-26-037247:0
2,210 shares0Common StockSEC:0001628280-26-037245:0
2,210 shares0Common StockSEC:0001628280-26-037243:0
531 shares@ US$62.632.7% of flowCommon StockSEC:0001628280-26-012831:1
504 shares@ US$62.631.8% of flowCommon StockSEC:0001628280-26-012832:1
13,373 shares0Common StockSEC:0001628280-26-012833:0
3,074 shares0Common StockSEC:0001628280-26-012832:0
2,415 shares0Common StockSEC:0001628280-26-012831:0
2,795 shares0Common StockSEC:0001628280-26-012829:0
5,000 shares@ US$66.4626.5% of flowCommon StockSEC:0001628280-26-009129:1
1,267 shares@ US$67.525.6% of flowCommon StockSEC:0001628280-26-009131:0
1,540 shares@ US$67.5216.9% of flowCommon StockSEC:0001628280-26-009129:0
3,135 shares@ US$33.845.9% of flowCommon StockSEC:0001894753-26-000003:1
6,809 shares@ US$53.1823.6% of flowCommon StockSEC:0001894753-26-000003:0
2,684 shares@ US$53.1823.1% of flowCommon StockSEC:0001870293-26-000004:0
25 of 364 declarations
About Proto Labs Inc
The largest sales at Proto Labs Inc come from successive executives: Donald G. Krantz, EUR 1,764,300 on March 14, 2016; John Way, Chief Financial Officer, EUR 1,516,324 on August 6, 2020; Victoria M. Holt, President and CEO, EUR 1,482,482 on February 16, 2021. In all, 76 sales weigh EUR 25.0 million (median EUR 228,652), against 7 purchases worth EUR 1,024,216 (median EUR 90,244), or 8% of open-market trades.
Arthur R. Baker III, Chief Technology Officer, made the two largest purchases: EUR 434,323 on December 1, 2021 and EUR 147,312 on September 1, 2016. Robert Bodor, President and CEO, bought EUR 132,864 on December 3, 2021. On August 4 and 5, 2025, 2 insiders bought for EUR 129,653.
Read moreShow less
The 364 filings from 24 filers, published from February 10, 2016 to September 25, 2026, include 215 grants and 60 option exercises. The annual peak is 61 in 2018, against 18 in 2023. The company, in Industry, has a market capitalisation of USD 2.09 billion, and insiders hold 1.3%. Over the last twelve months: 31 filings, 6 of them sales and none a purchase.
